Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2
Ang Gao, Zhilin Chen, Florencia Pereyra Segal, et al.
Nucleic Acids Research
|
March 13, 2016
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
Aleksandar Vojta, Paula Dobrinić, Vanja Tadić, et al.
Plos One
|
February 21, 2012
Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa
Boris Julg, Danielle Poole, Musie Ghebremichael, et al.
Immunity
|
June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
Nadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Nature Communications
|
December 18, 2025
Minor SHIV variants abrogate protective efficacy of broadly neutralizing antibodies in rhesus macaques
Victoria E K Walker-Sperling, Joseph Nkolola, Jinyan Liu, et al.
Journal of Virology
|
November 28, 2025
The functional antibody landscape in HIV post-treatment controllers is heterogeneous
Nicholas E Webb, Matthew J Gorman, Lily J Parker, et al.
Open Forum Infectious Diseases
|
December 10, 2021
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Robert W Finberg, Madiha Ashraf, Boris Julg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2022
Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs
Chuangqi Wang, Timothy E Schlub, Wen Han Yu, et al.
Elife
|
April 12, 2021
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
Deniz Cizmeci, Giuseppe Lofano, Evan Rossignol, et al.
Plos Pathogens
|
September 6, 2022
Evolution of functional antibodies following acute Epstein-Barr virus infection
Christina B Karsten, Yannic C Bartsch, Sally A Shin, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2
Ang Gao, Zhilin Chen, Florencia Pereyra Segal, et al.
Nucleic Acids Research
|
March 13, 2016
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
Aleksandar Vojta, Paula Dobrinić, Vanja Tadić, et al.
Plos One
|
February 21, 2012
Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa
Boris Julg, Danielle Poole, Musie Ghebremichael, et al.
Immunity
|
June 14, 2024
Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
Nadège Nziza, Wonyeong Jung, Maanasa Mendu, et al.
Nature Communications
|
December 18, 2025
Minor SHIV variants abrogate protective efficacy of broadly neutralizing antibodies in rhesus macaques
Victoria E K Walker-Sperling, Joseph Nkolola, Jinyan Liu, et al.
Journal of Virology
|
November 28, 2025
The functional antibody landscape in HIV post-treatment controllers is heterogeneous
Nicholas E Webb, Matthew J Gorman, Lily J Parker, et al.
Open Forum Infectious Diseases
|
December 10, 2021
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Robert W Finberg, Madiha Ashraf, Boris Julg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2022
Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs
Chuangqi Wang, Timothy E Schlub, Wen Han Yu, et al.
Elife
|
April 12, 2021
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
Deniz Cizmeci, Giuseppe Lofano, Evan Rossignol, et al.
Plos Pathogens
|
September 6, 2022
Evolution of functional antibodies following acute Epstein-Barr virus infection
Christina B Karsten, Yannic C Bartsch, Sally A Shin, et al.
Page
of 7